共 6 条
- [2] Annual Meeting of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR) during the Symposium "Novel Approaches for the Discovery and the Development of Anticancer Agents INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (12) : 566 - 608
- [4] A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (7-8) : 333 - 338
- [5] Meeting of ESC Working Group on Cardiovascular Pharmacology and Drug Therapy and 3rd World Conference of International Academy of Cardiovascular Sciences (IACS) COPENHAGEN (Denmark) - June 18-19, 2009 'Sudden Cardiac Death - Cardiovascular Therapy' FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 (05) : 534 - 534
- [6] A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN) EUROPEAN JOURNAL OF CANCER, 2015, 51 : S517 - S517